Michael Partin
Family · Columbia, KYNPI 1730701053
Payments from drug & device makers
Across 57 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$150
- Lilly USA, LLC$81
- AstraZeneca$70
- Pfizer$67
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$51
- Kowa Pharmaceuticals America, Inc.$45
- plus $474 from 19 others
What the payments were for
- Food & beverage$938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $150 |
| Lilly USA, LLC | 5 | $81 |
| AstraZeneca | 5 | $70 |
| Pfizer | 4 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $51 |
| Kowa Pharmaceuticals America, Inc. | 2 | $45 |
| Merck | 3 | $42 |
| Novo Nordisk | 3 | $42 |
| Lundbeck LLC | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Amgen | 2 | $33 |
| GSK | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Boehringer Ingelheim | 2 | $28 |
| Atricure, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 2 | $26 |
| Metacel Pharmaceuticals LLC | 1 | $20 |
| Mylan Specialty L.p. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Genentech USA, Inc. | 1 | $7 |
| Phathom Pharmaceuticals, Inc. | 1 | $2 |
How this compares
$938 in reported general payments places this provider in the 60th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $79,663 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $19,969 |
| FarxigaDapagliflozin Propanediol | 17 | $11,689 |
| UbrelvyUbrogepant | 11 | $11,272 |
| Spiriva RespimatTiotropium Bromide | 14 | $7,223 |
| VascepaIcosapent Ethyl | 17 | $6,398 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 134 | $3,511 |
| Dexlansoprazole DrDexlansoprazole | 18 | $3,507 |
| AlvescoCiclesonide | 12 | $3,236 |
| Epinephrine | 11 | $1,639 |
| Gabapentin | 172 | $1,476 |
| Fluticasone Propionate | 149 | $1,366 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,349 |
| Ventolin HfaAlbuterol Sulfate | 20 | $1,106 |
| Glipizide | 16 | $989 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $42 | $79,66370 claims |
| GSKTrelegy Ellipta | $31 | $19,96931 claims |
| AstraZenecaFarxiga | $70 | $11,68917 claims |
| AbbVieUbrelvy | $150 | $11,27211 claims |
| Boehringer IngelheimSpiriva Respimat | $28 | $7,22314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,374 family providers in Kentucky.
Other family in Columbia
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.